62

Endometriosis By Prof. Rafia Baloch

Embed Size (px)

Citation preview

Page 1: Endometriosis By Prof. Rafia Baloch
Page 2: Endometriosis By Prof. Rafia Baloch
Page 3: Endometriosis By Prof. Rafia Baloch
Page 4: Endometriosis By Prof. Rafia Baloch

Prof. Rafia BalochHead of Department

Gynaecology & Obstetrics SZWH, CMC & SMBBMU Larkana

Page 5: Endometriosis By Prof. Rafia Baloch

Learning Objectives

• Identify the symptoms and consequences associated with endometriosis

• Describe various treatment options in the management of endometriosis

Page 6: Endometriosis By Prof. Rafia Baloch

PREVALENCE

• NOT PRECISELY KNOWN—2-5%• 20-40% OF WOMEN IN INFERTILE COUPLE

RELATIONSHIPS VS 5% OF FERTILE WOMEN• BUT ALSO FOUND IN 6-43% OF WOMEN

UNDERGOING LAPAROSCOPIC STERILIZATION• 52% OF TEENAGES WITH CPP SYNDROME

Page 7: Endometriosis By Prof. Rafia Baloch

Definition• Endometriosis is a disease in which

endometrial glands and stroma implant and grow in areas outside the uterus

• Most commonly implants are found in the pelvis

• Lesions may occur at distant sites: pleural cavity, liver, kidney, gluteal muscles, bladder, etc

Page 8: Endometriosis By Prof. Rafia Baloch

Features of Endometriosis

• Prevalence 2-50% of women; 21-47% of infertility cases

• Exposure to ovarian hormones appears to be essential

• No known racial or socioeconomic predilection

• Severe disease may occur in families

Page 9: Endometriosis By Prof. Rafia Baloch

Is Endometriosis Increasing?• 1965-1984, endometriosis rose from 10 to 19% as

primary indication for hysterectomy

• Simultaneously, a trend of more conservative therapies was occurring, which suggests a true increase in the incidence

• Theories include delay of childbearing, less use of OCs, and exposure to environmental toxins such as dioxin

Page 10: Endometriosis By Prof. Rafia Baloch

Etiologies of Endometriosis• Sampson's theory: Retrograde menses and peritoneal

implantation– Most women retrograde menstruate

• Meyer's theory: Coelomic metaplasia– Low incidence of pleural disease

• Halban's theory: Hematogenous or lymphatic spread to distant tissues – Does not explain gravity dependent disease sites

• Immunogenic defect

Page 11: Endometriosis By Prof. Rafia Baloch

Normal Pelvic Structures

Page 16: Endometriosis By Prof. Rafia Baloch

Stage I (Minimal) Stage II (Mild)

Stage III (Moderate) Stage IV (Severe)

Classification of Endometriosis

4* 9

11429

* Revised AFS Score

Page 17: Endometriosis By Prof. Rafia Baloch

Clinical Presentation

• Pelvic pain

• Infertility

• Pelvic mass

Page 18: Endometriosis By Prof. Rafia Baloch

Pelvic Pain• Frequency

– Cyclic: Variable length prior to and after menses

– Acyclic: constant and unrelenting

• Associated activities– May include dyspareunia, dysuria, or

dyschezia• Other sites of pain

– Muscle regions– Distant tissues

Page 19: Endometriosis By Prof. Rafia Baloch

Infertility• Moderate to severe disease

– Adhesions – Distortion of normal anatomy– Prevent sperm-egg interaction

• Minimal to mild disease– Mild infertility– Mechanism(s) unknown

Page 20: Endometriosis By Prof. Rafia Baloch

symptoms

• 90% severe dysmenorrohoea• 70% chronic pelvic pain• 75% dyspareunia• 55% infertility

Page 21: Endometriosis By Prof. Rafia Baloch

Risk factors

• Single/nulliparous• Early menarche• Non oral contraception• Non smoker shorter cycle/longer duration of flow• Dysplastic naevus syndrome, melanoma

Page 22: Endometriosis By Prof. Rafia Baloch

Physical Findings

• Tender nodules along the uterosacral ligaments or in the cul-de-sac, especially just before menses

• Pain or induration without nodules commonly in the cul-de-sac or rectovaginal septum

• Uterine or adnexal fixation, or an adnexal mass

Page 23: Endometriosis By Prof. Rafia Baloch

Diagnosis of Endometriosis• Direct visualization of implants

– Laparoscopically– Conscious pain mapping

• Imaging of endometriomas– MR appears to be best (3 mm implants)– Ultrasound helpful in office setting

• Biochemical markers – Lack specificity

Page 26: Endometriosis By Prof. Rafia Baloch

Endometriosis

Page 27: Endometriosis By Prof. Rafia Baloch

Ultrasound of Endometrioma

Page 28: Endometriosis By Prof. Rafia Baloch

MR of Endometrioma

Page 29: Endometriosis By Prof. Rafia Baloch

Endometrioma

Page 30: Endometriosis By Prof. Rafia Baloch
Page 31: Endometriosis By Prof. Rafia Baloch
Page 32: Endometriosis By Prof. Rafia Baloch
Page 33: Endometriosis By Prof. Rafia Baloch
Page 34: Endometriosis By Prof. Rafia Baloch
Page 35: Endometriosis By Prof. Rafia Baloch
Page 36: Endometriosis By Prof. Rafia Baloch
Page 37: Endometriosis By Prof. Rafia Baloch
Page 38: Endometriosis By Prof. Rafia Baloch

Familial association

• Relative Risk to siblings 2.3 overall

• Relative Risk to sibs if severe endo 15

Page 39: Endometriosis By Prof. Rafia Baloch

Infertility mechanisms

Adhesions distorsion

Increased PGs

Cell mediated gamete inj

Defective folliculogenisis

Chronic salpingitis

Activated macrophag

Increased prev. ABs

LUFFS

Altered tubal motil

Cytokines Fertilization failure

hyperprolactinaemia

Impaired oocyte pick up

Sperm phagocytosed

Early spon abortion

Luteal phase deficency

Page 40: Endometriosis By Prof. Rafia Baloch

Treatment of pain

• NSAIDS: all significantly better than placebo, studies vary which one is best

• Naproxen >mefanemic acid>aspirin• Naproxen=ibuprofen• Naproxen only drug with significant SEs

Page 41: Endometriosis By Prof. Rafia Baloch

treatment of menstrual painTreatment level of evidenceSimple analgesics 1Herbal remedies 1 alcohol 2Antidepressants/anxiolytics 2OCPs 1NSAIDS 3

Page 42: Endometriosis By Prof. Rafia Baloch

ENDOMETRIOSIS PAIN

• PSYCO-PHYSICAL TREATMENTS-ACCUPUNCTURE, MESSAGE, RELAXATION, TENS

• EXERCISE• ANTI-OESTROGEN DRUGS• LAPAROSCOPY/ OPEN SURGERY

Page 43: Endometriosis By Prof. Rafia Baloch

LIMITATIONS OF DRUG THERAPY• ONLY SHRINKS SOME TYPES OF

ENDOMETRIOSIS WHICH ARE OESTROGEN SENSITIVE IE RED AND BLISTER APPEARANCE NOT BROWN, BLACK AND WHITE

• SHRINKAGE NOT COMPLETE- USUALY LEAVES MICRO DISEASE

• RESULTS FOR INFERTILITY TREATMENT NO BETTER THAN NO TREATMENT

• DOES NOT DEAL WITH ADHESIONS

Page 44: Endometriosis By Prof. Rafia Baloch
Page 45: Endometriosis By Prof. Rafia Baloch

Treatment of Endometriosis

• Management of pain– Surgery – Medical therapy

• Treatment of infertility– Surgery– Ovulation induction– Assisted reproductive technology

Page 46: Endometriosis By Prof. Rafia Baloch

Endometriosis

Page 47: Endometriosis By Prof. Rafia Baloch

Removal of Endometriosis

Page 48: Endometriosis By Prof. Rafia Baloch

Dissection of an Endometrioma

Tube

OvaryIncision

Removal Result

Page 49: Endometriosis By Prof. Rafia Baloch

Treatment of Pain• Medical management

(ovarian suppression, removal of estrogen)

– Oral contraceptives, progestin, danazol

– GnRH agonist with add-back

– Alternating GnRH agonist and OCs

– Aromatase inhibitors

Page 50: Endometriosis By Prof. Rafia Baloch

Medical Treatment

Ovary EstrogenEndometriosis

Tissue

Page 51: Endometriosis By Prof. Rafia Baloch

Medical Treatment

Ovary EstrogenEndometriosis

TissueOral contraceptivesDanazolGnRH agonists

Progestin

Page 52: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Estrogen

Page 53: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Estrogen

Cell growth

Page 54: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Aromatase

Estrogen

Cell growth

Page 55: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Aromatase

Estrogen

Cell growth

PGE2Cytokines

Page 56: Endometriosis By Prof. Rafia Baloch

Aromatase In Endometriosis• Aromatase is key for the biosynthesis of estrogen

• In patients aromatase expression is higher in endometriosis tissue than in normal endometrium

• In endometriosis tissue aromatase activity is stimulated by prostaglandin

• Estrogen synthesized by endometriotic tissue stimulates growth of lesions

Page 57: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Aromatase

Estrogen

Cell growth

PGE2Cytokines

Aromatase Inhibitors • Letrozole

• Exemestane • Anastrozole

Page 58: Endometriosis By Prof. Rafia Baloch

Role of Estrogen in Endometriosis

Aromatase

Estrogen

Cell growth

PGE2Cytokines

Aromatase Inhibitors • Letrozole

• Exemestane • Anastrozole• Danazol

Page 59: Endometriosis By Prof. Rafia Baloch

Treatment of Infertility• Removal of disease

– Surgery improve conception rates at all stages

• Ovulation induction– Gonadotropins with ovarian suppression – Insemination with either clomiphene or FSH

• Medical suppression of ovarian function– No benefit

• Assisted reproductive technology

Page 60: Endometriosis By Prof. Rafia Baloch

Prevention

• Early marriage• Avoid Vaginal examination during menses• Surgery during menses• Early Treatment of cryptomenorrhea

Page 61: Endometriosis By Prof. Rafia Baloch

MESSAGE

• Live only for a love of Allah follow Holy Quran & Prophet Hazrat Muhammad ملسو هيلع هللا ىلص‍

Page 62: Endometriosis By Prof. Rafia Baloch